Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 6282486, 10 pages
https://doi.org/10.1155/2017/6282486
Research Article

Comparison of Effects of Different Statins on Contrast-Induced Acute Kidney Injury in Rats: Histopathological and Biochemical Findings

Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Correspondence should be addressed to Ling-hong Shen and Ben He

Received 22 October 2016; Accepted 12 December 2016; Published 24 January 2017

Academic Editor: Massimo Collino

Copyright © 2017 Xiao-lei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. McCullough, “Contrast-induced acute kidney injury,” Journal of the American College of Cardiology, vol. 51, no. 15, pp. 1419–1428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Wichmann, R. W. Katzberg, S. E. Litwin et al., “Contrast-induced nephropathy,” Circulation, vol. 132, no. 20, pp. 1931–1936, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Narula, R. Mehran, G. Weisz et al., “Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy,” European Heart Journal, vol. 35, no. 23, pp. 1533–1540, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Zhang, L.-H. Shen, L.-H. Hu, and B. He, “Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis,” American Journal of Nephrology, vol. 33, no. 4, pp. 344–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Alpert, “Do statins reduce the risk of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary interventions?” Journal of the American College of Cardiology, vol. 63, no. 1, pp. 80–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Farmer, “Pleiotropic effects of statins,” Current Atherosclerosis Reports, vol. 2, no. 3, pp. 208–217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Wang, P. Qian, T. D. Yan, and K. Phan, “Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: a systematic review and trial sequential analysis,” International Journal of Cardiology, vol. 206, no. 1, pp. 143–152, 2016. View at Publisher · View at Google Scholar
  8. Y. Han, G. Zhu, L. Han et al., “Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease,” Journal of the American College of Cardiology, vol. 63, no. 1, pp. 62–70, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Leoncini, A. Toso, M. Maioli, F. Tropeano, S. Villani, and F. Bellandi, “Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS study (protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome),” Journal of the American College of Cardiology, vol. 63, no. 1, pp. 71–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Li, Y. Liu, L. Fu, C. Mei, and B. Dai, “Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials,” PloS One, vol. 7, no. 4, Article ID e34450, 2012. View at Google Scholar · View at Scopus
  11. Y. Zhou, W. J. Yuan, N. Zhu, and L. Wang, “Short-term, high-dose statins in the prevention of contrast-induced nephropathy: a systematic review and meta-analysis,” Clinical Nephrology, vol. 76, no. 6, pp. 475–483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Toso, M. Maioli, M. Leoncini et al., “Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease,” The American Journal of Cardiology, vol. 105, no. 3, pp. 288–292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Quintavalle, D. Fiore, F. De Micco et al., “Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury,” Circulation, vol. 126, no. 25, pp. 3008–3016, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Thompson, R. Razi, M. S. Lee et al., “Statin use prior to angiography for the prevention of contrast-induced acute kidney injury: a meta-analysis of 19 randomised trials,” EuroIntervention, vol. 12, no. 3, pp. 366–374, 2016. View at Publisher · View at Google Scholar
  15. A. C. Chyou, A. Thodge, D. N. Feldman, and R. V. Swaminathan, “Statins in the prevention of contrast-induced nephropathy,” Current Treatment Options in Cardiovascular Medicine, vol. 17, no. 4, p. 375, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sun, T. Zhang, P. Nie et al., “A novel rat model of contrast-induced acute kidney injury,” International Journal of Cardiology, vol. 172, no. 1, pp. e48–e50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Yamasowa, S. Shimizu, T. Inoue, M. Takaoka, and Y. Matsumura, “Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning,” The Journal of Pharmacology and Experimental Therapeutics, vol. 312, no. 1, pp. 153–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Y. Sözmen, B. Sözmen, F. K. Girgin et al., “Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation,” Clinical and Experimental Medicine, vol. 1, no. 4, pp. 195–199, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  20. M.-L. Hu, S. Louie, C. E. Cross, P. Motchnik, and B. Halliwell, “Antioxidant protection against hypochlorous acid in human plasma,” The Journal of Laboratory and Clinical Medicine, vol. 121, no. 2, pp. 257–262, 1993. View at Google Scholar · View at Scopus
  21. Phuong Nhi Bories and C. Bories, “Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase,” Clinical Chemistry, vol. 41, no. 6, pp. 904–907, 1995. View at Google Scholar · View at Scopus
  22. F. Faul, E. Erdfelder, A.-G. Lang, and A. Buchner, “GPower 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences,” Behavior Research Methods, vol. 39, no. 2, pp. 175–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Schönbeck and P. Libby, “Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?” Circulation, vol. 109, no. 21, supplement 1, pp. II18–II26, 2004. View at Google Scholar · View at Scopus
  24. R. P. Mason, M. F. Walter, and R. F. Jacob, “Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress,” Circulation, vol. 109, no. 21, supplement 1, pp. II34–II41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kaya, M. Kurt, I. H. Tanboğa et al., “Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-CIN trial),” Acta Cardiologica, vol. 68, no. 5, pp. 489–494, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Liu, Y.-H. Liu, N. Tan et al., “Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention,” PLoS ONE, vol. 9, no. 10, Article ID e111124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Lameire, W. Van Biesen, and R. Vanholder, “Acute kidney injury,” The Lancet, vol. 372, no. 9653, pp. 1863–1865, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Deng, G. Wu, C. Yang, Y. Li, Q. Jing, and Y. Han, “Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male rats,” Journal of Translational Medicine, vol. 13, no. 1, article no. 53, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Quintavalle, C. V. Anselmi, F. De Micco et al., “Neutrophil gelatinase-associated lipocalin and contrast-induced acute kidney injury,” Circulation Cardiovascular Interventions, vol. 8, no. 9, Article ID e002673, 2015. View at Google Scholar
  30. S. Sun, T. Zhang, D. Ding et al., “Circulating MicroRNA‐188, ‐30a, and ‐30e as early biomarkers for contrast‐induced acute kidney injury,” Journal of the American Heart Association, vol. 5, no. 8, Article ID e004138, 2016. View at Publisher · View at Google Scholar
  31. M. Schachter, “Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update,” Fundamental and Clinical Pharmacology, vol. 19, no. 1, pp. 117–125, 2005. View at Publisher · View at Google Scholar · View at Scopus